Chondrial Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Chondrial Therapeutics

Access the complete profile.

Chondrial Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	150 Monument Road Suite 207 Bala Cynwyd, PA 19004

Note: Revenues for privately held companies are statistical evaluations.


Chondrial Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Chondrial Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Chondrial Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Chondrial Therapeutics Annual Revenue and Growth Rate

Chondrial Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Chondrial Therapeutics's revenues are gauged from an analysis of company filings.

Chondrial Therapeutics's Income Statement (based on Industry Averages)

Chondrial Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Chondrial Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 21, 2020	0	0%	$15 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Chondrial Therapeutics is developing and marketing. Chondrial Therapeutics doesn't have any recent trademark applications, indicating Chondrial Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark

Date

LARIMAR THERAPEUTICS Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy

07/17/2020

See all trademarks and details in the Full Report.

Market Share of Chondrial Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Chondrial Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Chondrial Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RED NUCLEUS ENTERPRISES	Yardley, PA	100
LUMANITY	Morrisville, PA	53
VERANOVA	Wayne, PA	51
QUOTIENT SCIENCES - PHILADELPHIA	Boothwyn, PA	37
MARINUS PHARMACEUTICALS	Wayne, PA	26
RESEARCH	Horsham, PA	9

Other Companies at 150 Monument Road, Bala Cynwyd PA

Company	Headquarters	Revenue ($ MM)
PUROLITE	Bala Cynwyd, PA	100
SIMPSON SENIOR SERVICES	Bala Cynwyd, PA	67
PATINA HEALTH	Bala Cynwyd, PA	5
PAPAL FOUNDATION	Bala Cynwyd, PA	2
GAMBLE & ASSOCIATES	Bala Cywnyd, PA	1

Future Competition: Chondrial Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Chondrial Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)